Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Luster

Showing results (71-80 of 181) with videos related to

Pageof 19
Sort By:
Nuklearmedizin. Nuclear Medicine|August 21, 2018
[Iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma]Frederik A Verburg, Frank Grünwald, Michael Lassmann, et al.
Endocrine-Related Cancer|March 25, 2005
rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive reviewMarkus Luster, Francesco Lippi, Barbara Jarzab, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 12, 2013
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseasesHeribert Hänscheid, Cristina Canzi, Wolfgang Eschner, et al.
Deutsches Arzteblatt International|April 22, 2026
Thyroid Cancer: Epidemiology, Diagnosis, and TreatmentKatharina Holzer, Viktoria Florentine Koehler, Jörg Bojunga, et al.
The Lancet. Diabetes & Endocrinology|May 6, 2014
Definition and management of radioactive iodine-refractory differentiated thyroid cancerMartin Schlumberger, Marcia Brose, Rosella Elisei, et al.
Clinical Endocrinology|October 30, 2009
A comparison of prognostic classification systems for differentiated thyroid carcinomaFrederik A Verburg, Uwe Mäder, Cas L J J Kruitwagen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2013
Nothing new under the nuclear sun: towards 80 years of theranostics in nuclear medicineFrederik A Verburg, Alexander Heinzel, Heribert Hänscheid, et al.
Endocrine|November 2, 2020
Perioperative diagnostics of patients referred for radioiodine therapy of differentiated thyroid carcinoma: referral center experience in an iodine-insufficient countryFriederike Eilsberger, R Michael Tuttle, Damiano Librizzi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 17, 2019
Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decadeFrederik A Verburg, Glenn Flux, Luca Giovanella, et al.
Nuklearmedizin. Nuclear Medicine|December 11, 2024
The impact of the xSPECT reconstruction algorithms on the recovery coefficients value for small tumors: a phantom study with 177LuAli Ebrahimifard, Hossein Rajabi, Parham Geramifar, et al.
Pageof 19

Showing results (71-80 of 181) with videos related to

Sort By:
Pageof 19
Nuklearmedizin. Nuclear Medicine|August 21, 2018
[Iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma]Frederik A Verburg, Frank Grünwald, Michael Lassmann, et al.
Endocrine-Related Cancer|March 25, 2005
rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive reviewMarkus Luster, Francesco Lippi, Barbara Jarzab, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 12, 2013
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseasesHeribert Hänscheid, Cristina Canzi, Wolfgang Eschner, et al.
Deutsches Arzteblatt International|April 22, 2026
Thyroid Cancer: Epidemiology, Diagnosis, and TreatmentKatharina Holzer, Viktoria Florentine Koehler, Jörg Bojunga, et al.
The Lancet. Diabetes & Endocrinology|May 6, 2014
Definition and management of radioactive iodine-refractory differentiated thyroid cancerMartin Schlumberger, Marcia Brose, Rosella Elisei, et al.
Clinical Endocrinology|October 30, 2009
A comparison of prognostic classification systems for differentiated thyroid carcinomaFrederik A Verburg, Uwe Mäder, Cas L J J Kruitwagen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2013
Nothing new under the nuclear sun: towards 80 years of theranostics in nuclear medicineFrederik A Verburg, Alexander Heinzel, Heribert Hänscheid, et al.
Endocrine|November 2, 2020
Perioperative diagnostics of patients referred for radioiodine therapy of differentiated thyroid carcinoma: referral center experience in an iodine-insufficient countryFriederike Eilsberger, R Michael Tuttle, Damiano Librizzi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 17, 2019
Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decadeFrederik A Verburg, Glenn Flux, Luca Giovanella, et al.
Nuklearmedizin. Nuclear Medicine|December 11, 2024
The impact of the xSPECT reconstruction algorithms on the recovery coefficients value for small tumors: a phantom study with 177LuAli Ebrahimifard, Hossein Rajabi, Parham Geramifar, et al.
Pageof 19